Three different antibodies have been frequently used to study, immunohistochemically, the expression of FSHR in human tumors: sc-13935 [23,24,25,26,27], sc-7798 [27,28], and FSHR323 [15,20,21,22,29,30], and are claimed to be suitable tools for immunohistochemical analysis of cancer tissues. Here, FSHR is linked to cancer.